Jan. 28, 2025 — A new study explores the effects of both recent and lifetime cannabis use on brain function during cognitive tasks. The study, the largest of its kind ever to be completed ...
If you want to avoid THC, a CBD isolate product is likely your safest bet. The oils on our list may be effective, and we include our editors’ favorites here. If you’re interested in trying ...
Medical cannabis is legal in the UK. This means that in some circumstances, specialist doctors may prescribe it to treat epilepsy. On this page, we talk about the different types of medical cannabis ...
In the study, scientists used a spray. Nasal vestibulitis is not usually an emergency. However, if a person with a weakened immune system develops a fever, they should go to the emergency room ...
Each gummy contains 20 to 50 milligrams (mg) of CBD and up to 2 mg of tetrahydrocannabinol (THC). You can choose from three flavors: watermelon, berry, or peach. They may mask the natural ...
In July 2022, breweries and cideries across Minnesota were handed a legislative boon: The ability to make and sell THC drinks alongside their craft beers, ciders, and seltzers. Since then, the Twin ...
In a small 2017 study, adults with ADHD who used a cannabis spray saw no difference in cognitive performance but had improvements in hyperactivity and impulsivity. Another small study in 2022 ...
Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...